Cimicoxib is an imidazole substituted at positions 1, 4 and 5 by 4-aminosulfonylphenyl, chloro and 3-fluoro-4-methyoxyphenyl groups respectively. A selective cyclooxygenase 2 inhibitor, it is used in veterinary medicine for the control of pain and inflammation associated with osteoarthritis in dogs. Among its listed roles, it functions as a cyclooxygenase 2 inhibitor and a non-steroidal anti-inflammatory drug. It is a sulfonamide, a member of imidazoles, an organochlorine compound, an organofluorine compound and an aromatic ether. It is grouped under the following drug class(es): Cyclooxygenase‑2 (COX‑2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAID). The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Cimalgex and Cimicoxibum. Its PubChem CID is 213053.
Cimicoxib
| CAS No | 265114-23-6 |
|---|---|
| Molecular Formula | C16H13ClFN3O3S |
| Molecular Weight | 381.8 g/mol |
| Synonyms | 4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cimicoxib is an imidazole substituted at positions 1, 4 and 5 by 4-aminosulfonylphenyl, chloro and 3-fluoro-4-methyoxyphenyl groups respectively. A selective cyclooxygenase 2 inhibitor, it is used in veterinary medicine for the control of pain and inflammation associated with osteoarthritis in dogs.
The listed CAS number is 265114-23-6.
The listed molecular formula is C16H13ClFN3O3S.
The listed molecular weight is 381.8 g/mol.
4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide.
The source lists Cimalgex and Cimicoxibum.